Search results
Results from the WOW.Com Content Network
Malhotra denounces what he calls the government's "obsession" with levels of total cholesterol, which, he says, has led to the overmedication of millions of people with statins, and has diverted attention from the "more egregious" risk factor of atherogenic dyslipidaemia. [66] He has questioned the worth of statins, and campaigned against their ...
The lipid hypothesis (also known as the cholesterol hypothesis) is a medical theory postulating a link between blood cholesterol levels and the occurrence of cardiovascular disease. A summary from 1976 described it as: "measures used to lower the plasma lipids in patients with hyperlipidemia will lead to reductions in new events of coronary ...
A new analysis re-evaluates statins and who should use them. Statins are widely used to help lower cholesterol. Using a new analysis, researchers found that millions of people may be taking ...
Statins are effective in decreasing mortality in people with pre-existing cardiovascular disease. [34] Pre-existing disease can have many manifestations. Defining illnesses include a prior heart attack, stroke, stable or unstable angina, aortic aneurysm, or other arterial ischemic disease, in the presence of atherosclerosis. [21]
Dr. Robert Lufkin says he taught lies in medical school about weight loss, diet, high blood pressure, and statins to prevent heart disease. Experts respond.
A new way of determining heart disease risk may result in millions fewer people getting prescriptions for statins, according to new research. Heart doctors warned, however, that more information ...
Type 2 statins Statins that are fully synthetic and have larger groups linked to the HMG-like moiety are often referred to as type 2 statins. One of the main differences between the type 1 and type 2 statins is the replacement of the butyryl group of type 1 statins by the fluorophenyl group of type 2 statins.
Statins appear to be effective at preventing cardiovascular disease and death in older adults, according to new research. Most clinical trials evaluating statins have not included people 75 and ...